ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,748Medicare Part D Prescriptions Filled, Including Refills

Rank: 268 out of 1185

$434K Total Retail Price of All Prescriptions

Rank: 348 out of 1185

279 Patients Receiving at Least One Drug in Part D
47%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 279 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

38% of this provider’s 279 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 3,246 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
HYDROCODONE-ACETAMINOPHEN 686 192 S3 1 2
SIMVASTATIN 301 155 2 5
GABAPENTIN 300 106 3 13
MELOXICAM 262 84 4 27
OMEPRAZOLE 236 79 5 6
ZOLPIDEM TARTRATE 206 55 6 15
METFORMIN HCL 203 103 7 9
LEVOTHYROXINE SODIUM 181 94 8 3
TRAMADOL HCL 176 58 9 16
OXYCODONE HCL 174 12 S2 10 70
CARISOPRODOL 162 31 R 11 87
TIZANIDINE HCL 160 17 12 113
NEXIUM 158 42 13 19
OXYCODONE HCL-ACETAMINOPHEN 155 13 S2 14 82
AZITHROMYCIN 126 51 15 39
FUROSEMIDE 120 60 16 8
LISINOPRIL 118 78 17 4
CITALOPRAM HBR 114 32 18 22
PRAVASTATIN SODIUM 107 74 19 7
PROMETHAZINE HCL 104 20 R 20 76
LISINOPRIL-HYDROCHLOROTHIAZIDE 103 41 21 14
AMLODIPINE BESYLATE 92 72 22 1
RANITIDINE HCL 88 38 23 17
GLIMEPIRIDE 87 27 24 49
CYCLOBENZAPRINE HCL 79 0 R 25 53
DICLOFENAC SODIUM 77 21 26 81
FENOFIBRATE 75 39 27 55
METOPROLOL SUCCINATE 72 43 28 20
METOPROLOL TARTRATE 71 56 29 10
CYMBALTA 71 17 29 44
JANUVIA 68 0 31 68
ATENOLOL 67 50 32 28
CEPHALEXIN 65 15 33 103
HYDROCHLOROTHIAZIDE 64 21 34 12
ATORVASTATIN CALCIUM 61 15 35 11
CIPROFLOXACIN HCL 60 37 36 62
TAMSULOSIN HCL 58 28 37 34
CLOPIDOGREL 58 36 37 31
DEXILANT 57 0 39 189
AMLODIPINE BESYLATE-BENAZEPRIL 56 24 40 42
GEMFIBROZIL 56 25 40 119
DONEPEZIL HCL 54 42 42 32
PREDNISONE 54 14 42 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 15, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.